Skip to content
Search

Latest Stories

RPS and Pharmacist Support host roundtable to explore actions needed to support staff

The Royal Pharmaceutical Society (RPS) and Pharmacist Support hosted a roundtable on the impact of pharmacy workforce wellbeing on patient safety on Wednesday (17 May).

It also released its annual Workforce Wellbeing Survey which showed continued pressures on pharmacy teams.


The discussion explored the actions needed to support staff so they can continue providing safe and effective patient care and included representatives from the NHS, professional bodies, employers, trade unions, education and regulators.

A report of the roundtable will be published in the summer.

Amandeep Doll, RPS Head of Professional Belonging, said: “We know that pharmacy teams go above and beyond for their patients, but are also under enormous pressure.

“Now more than ever, we need to strive to make the pharmacy profession more inclusive and ensure that everyone’s wellbeing is supported.

“It is vital that we do all we can to encourage people into pharmacy and to support them so they can enhance their skills, develop their careers, and continue to deliver high-quality patient care.

“This discussion was a welcome step and showed that making a difference for staff wellbeing requires a concerted effort from stakeholders across the whole of pharmacy.

“RPS will produce a report of the discussion and as a group we have committed to meeting again in six months.”

In a joint statement RPS commented: “Pharmacy organisations, regulators, unions and employers heard about the well recognised correlations between the wellness and wellbeing of students, academics and the clinical workforce and the impact that this has on workforce effectiveness, patient safety and patient outcomes.

With continued pressure on pharmacy teams and the health service, it is more important than ever to work together so that patients can continue to access to high-quality, adequately staffed and safe pharmacy services.

Prioritising staff wellbeing and leadership within systems supports higher-quality and safer patient care and improves workforce retention.

The collaborative roundtable discussion highlighted the importance of supporting pharmacy teams across all sectors of practice to deliver patient care through healthy working environments, access to appropriate rest breaks, and opportunities for professional development.

Staff should feel empowered to use their professional judgement in the interests of patients and the public. Staff must also be given the support, training, and supervision they need to help enable them to complete their professional duties.

Solutions to the challenges facing workforce well-being require interventions that go beyond the individual. Making the health service a better place to work must be a shared endeavour so that we can continue to meet the needs of our patients and support our pharmacy people.”

The statement was supported by Association of Pharmacy Technicians, UK (APTUK); British Pharmaceutical Students Association (BPSA);  Care Quality Commission (CQC);  General Pharmaceutical Council (GPhC); Guild of Healthcare Pharmacists (GHP); National Pharmacy Association (NPA); Pharmacists Defence Association (PDA); Pharmacy School Council (PhSC); Community Pharmacy England (CPE); Pharmacist Support; and Royal Pharmaceutical Society (RPS).

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less